Inhibition of human cytochrome P450 3A4 activity by zinc(II) ion

被引：7
|
作者：
Kim, JS
Yun, CH [1 ]
机构：
[1] Chonnam Natl Univ, Hormone Res Ctr, Kwangju 500757, South Korea
[2] Paichai Univ, AngioLab, Taejon 302735, South Korea
[3] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea
来源：
TOXICOLOGY LETTERS | 2005年 / 156卷 / 03期
关键词：
cytochrome P450 3A4; Zn(II) ion; NADPH-cytochrome P450 reductase; cytochrome b(5); testosterone 6 beta-hydroxylation activity;
D O I：
10.1016/j.toxlet.2004.12.006
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
Effects of Zn2+ on the activity and conformation of cytochorome P450 3A4 (CYP3A4) were investigated. Zn2+ specifically inhibited the testosterone 6 beta-hydroxylation activity of CYP3A4 with an IC50 value of 27 mu M. Zn2+ inhibited the CO-binding spectra of CYP3A4 reduced by NADPH-cytochrome P450 reductase (CPR) and NADPH only in the presenceof b(5).Zn2+-induced conformational changes of CYP3A4 were monitored by CD and intrinsic fluorescence. Zn2+ showed no significant effects on the activity of CYP3A4 supported by tert-butyl hydroperoxide, an oxygen surrogate, and on the reduction of b(5) by CPR and NADPH. These results suggest that the inhibitory effects of Zn2+ come from preventing the stimulation of b(5) on CYP3A4 activity. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：341 / 350
页数：10
相关论文
共 50 条
  • [41] Thermodynamic landscape of testosterone binding to human cytochrome P450 3A4
    Roberts, AG
    Campbell, AP
    Atkins, WM
    DRUG METABOLISM REVIEWS, 2004, 36 : 69 - 69
  • [42] Chromatographic assays of drug oxidation by human cytochrome P450 3A4
    Sohl, Christal D.
    Cheng, Qian
    Guengerich, F. Peter
    NATURE PROTOCOLS, 2009, 4 (09) : 1252 - 1257
  • [43] The one-electron autoxidation of human cytochrome p450 3A4
    Denisov, Ilia G.
    Grinkova, Yelena V.
    McLean, Mark A.
    Sligar, Stephen G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (37) : 26865 - 26873
  • [44] Kohonen maps for prediction of binding to human cytochrome P450 3A4
    Balakin, KV
    Ekins, S
    Bugrim, A
    Ivanenkov, YA
    Korolev, D
    Nikolsky, YV
    Skorenko, AV
    Ivashchenko, AA
    Savchuk, NP
    Nikolskaya, T
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (10) : 1183 - 1189
  • [45] Chromatographic assays of drug oxidation by human cytochrome P450 3A4
    Christal D Sohl
    Qian Cheng
    F Peter Guengerich
    Nature Protocols, 2009, 4 : 1252 - 1257
  • [46] Role of human cytochrome p450 3A4 in metabolism of medroxyprogesterone acetate
    Kobayashi, K
    Mimura, N
    Fujii, H
    Minami, H
    Sasaki, Y
    Shimada, N
    Chiba, K
    CLINICAL CANCER RESEARCH, 2000, 6 (08) : 3297 - 3303
  • [47] Expression of human cytochrome p450 3A4 gene in Schizosaccharomyces pombe
    Palabiyik, Bedia
    Karaer, Semian
    Arda, Nazli
    Toker, Sidika Erturk
    Temizkan, Guler
    Kelly, Steven
    Sarikaya, Aysegul Topal
    BIOLOGIA, 2008, 63 (03) : 450 - 454
  • [48] Interaction of methadone with substrates of human hepatic cytochrome P450 3A4
    Iribarne, C
    Dreano, Y
    Bardou, LG
    Menez, JF
    Berthou, F
    TOXICOLOGY, 1997, 117 (01) : 13 - 23
  • [49] Metabolism of organochlorine pesticides: The role of human cytochrome P450 3A4
    Mehmood, Z
    Williamson, MP
    Kelly, DE
    Kelly, SL
    CHEMOSPHERE, 1996, 33 (04) : 759 - 769
  • [50] Inhibition of cytochrome P450 3A4 by a pyrimidineimidazole: Evidence for complex heme interactions
    Hutzler, J. Matthew
    Melton, Roger J.
    Rumsey, Jeanne M.
    Schnute, Mark E.
    Locuson, Charles W.
    Wienkers, Larry C.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (12) : 1650 - 1659
12345